{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:34:05Z","timestamp":1792791245298,"version":"4.5.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Putian University 2022 university-level scientific research project","award":["2022105"],"award-info":[{"award-number":["2022105"]}],"id":[{"id":"https:\/\/ror.org\/00jmsxk74","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Putian University 2022 university-level scientific research project","award":["2022105"],"award-info":[{"award-number":["2022105"]}],"id":[{"id":"https:\/\/ror.org\/00jmsxk74","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Putian University 2022 university-level scientific research project","award":["2022105"],"award-info":[{"award-number":["2022105"]}],"id":[{"id":"https:\/\/ror.org\/00jmsxk74","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Putian University 2022 university-level scientific research project","award":["2022105"],"award-info":[{"award-number":["2022105"]}],"id":[{"id":"https:\/\/ror.org\/00jmsxk74","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-89063-4","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T13:15:07Z","timestamp":1739279707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Triamcinolone acetonide and botulinum toxin A for upper eyelid retraction in thyroid-associated ophthalmopathy"],"prefix":"10.1038","volume":"15","author":[{"given":"Zhiqing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maodong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3499-6550","authenticated-orcid":false,"given":"Xiaoqing","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"key":"89063_CR1","doi-asserted-by":"publisher","DOI":"10.18502\/jovr.v15i1.5948","author":"A Bagheri","year":"2020","unstructured":"Bagheri, A., Abbaszadeh, M. & Yazdani, S. Intraorbital Steroid Injection for active thyroid ophthalmopathy. J. N Vis. Res. https:\/\/doi.org\/10.18502\/jovr.v15i1.5948 (2020).","journal-title":"J. N Vis. Res."},{"key":"89063_CR2","doi-asserted-by":"crossref","unstructured":"Tu, X., Dong, Y., Zhang, H. & Su, Q. Corticosteroids for Graves\u2019 Ophthalmopathy: Systematic Review and Meta-Analysis. BioMed Research International 1\u20139 (2018). (2018).","DOI":"10.1155\/2018\/4845894"},{"key":"89063_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/01676830.2020.1814351","volume":"40","author":"GO Karabulut","year":"2020","unstructured":"Karabulut, G. O. et al. An algorithm for Botulinum toxin A injection for upper eyelid retraction associated with thyroid eye disease: long-term results. Orbit 40, 381\u2013388 (2020).","journal-title":"Orbit"},{"key":"89063_CR4","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1089\/thy.2000.10.1093","volume":"10","author":"DH Khoo","year":"2000","unstructured":"Khoo, D. H. et al. Graves\u2019 Ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: Prevalence, Natural History, and thyrotropin receptor antibody levels. Thyroid 10, 1093\u20131100 (2000).","journal-title":"Thyroid"},{"key":"89063_CR5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ophtha.2011.08.039","volume":"119","author":"GH Milbratz","year":"2012","unstructured":"Milbratz, G. H., Garcia, D. M., Guimar\u00e3es, F. C. & Cruz, A. A. V. multiple radial midpupil lid distances: a simple method for lid Contour Analysis. Ophthalmology 119, 625\u2013628 (2012).","journal-title":"Ophthalmology"},{"key":"89063_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.beem.2011.11.001","volume":"26","author":"WM Wiersinga","year":"2012","unstructured":"Wiersinga, W. M. Quality of life in Graves\u2019 ophthalmopathy. Best Pract. Res. Clin. Endocrinol. Metab. 26, 359\u2013370 (2012).","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"89063_CR7","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1136\/bjo.88.1.75","volume":"88","author":"JJ Park","year":"2004","unstructured":"Park, J. J. Assessing quality of life in Australian patients with Graves\u2019 ophthalmopathy. Br. J. Ophthalmol. 88, 75\u201378 (2004).","journal-title":"Br. J. Ophthalmol."},{"key":"89063_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1097\/IOP.0000000000001120","volume":"34","author":"SM Young","year":"2018","unstructured":"Young, S. M., Kim, Y. D., Lang, S. S. & Woo, K. I. Transconjunctival Triamcinolone Injection for Upper lid retraction in thyroid Eye Disease\u2014A New Injection Method. Ophthalmic Plast. Reconstr. Surg. 34, 587\u2013593 (2018).","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"89063_CR9","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1136\/bjophthalmol-2017-310695","volume":"102","author":"ABD Grisolia","year":"2017","unstructured":"Grisolia, A. B. D., Couso, R. C., Matayoshi, S., Douglas, R. S. & Brice\u00f1o, C. A. Non-surgical treatment for eyelid retraction in thyroid eye disease (TED). Br. J. Ophthalmol. 102, 158\u2013163 (2017).","journal-title":"Br. J. Ophthalmol."},{"key":"89063_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/IOP.0000000000000130","volume":"30","author":"JC Kohn","year":"2014","unstructured":"Kohn, J. C. et al. Hyaluronic Acid Gel Injection for Upper Eyelid retraction in thyroid Eye Disease. Ophthalmic Plast. Reconstr. Surg. 30, 400\u2013404 (2014).","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"89063_CR11","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1097\/SCS.0b013e3182646043","volume":"23","author":"JM Lee","year":"2012","unstructured":"Lee, J. M., Lee, H., Park, M. & Baek, S. Subconjunctival Injection of Triamcinolone for the Treatment of Upper Lid Retraction Associated with thyroid Eye Disease. J. Craniofac. Surg. 23, 1755\u20131758 (2012).","journal-title":"J. Craniofac. Surg."},{"key":"89063_CR12","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1007\/s00417-012-2153-y","volume":"251","author":"SJ Lee","year":"2012","unstructured":"Lee, S. J. et al. Treatment of upper eyelid retraction related to thyroid-associated ophthalmopathy using subconjunctival triamcinolone injections. Graefe\u2019s Archive Clin. Experimental Ophthalmol. 251, 261\u2013270 (2012).","journal-title":"Graefe\u2019s Archive Clin. Experimental Ophthalmol."},{"key":"89063_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jcjo.2011.12.005","volume":"47","author":"D Xu","year":"2012","unstructured":"Xu, D., Liu, Y., Xu, H. & Li, H. Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy. Can. J. Ophthalmol. 47, 34\u201341 (2012).","journal-title":"Can. J. Ophthalmol."},{"key":"89063_CR14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1038\/eye.2008.165","volume":"23","author":"PG Costa","year":"2008","unstructured":"Costa, P. G., Saraiva, F. P., Pereira, I. C., Monteiro, M. L. R. & Matayoshi, S. Comparative study of Botox\u00ae injection treatment for upper eyelid retraction with 6-month follow-up in patients with thyroid eye disease in the congestive or fibrotic stage. Eye23, 767\u2013773 (2008).","journal-title":"Eye"},{"key":"89063_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/sj.eye.6700690","volume":"18","author":"MJ Shih","year":"2004","unstructured":"Shih, M. J., Liao, S. L. & Lu, H. Y. A single transcutaneous injection with Botox\u00ae for dysthyroid lid retraction. Eye18, 466\u2013469 (2004).","journal-title":"Eye"},{"key":"89063_CR16","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1097\/00002341-200405000-00001","volume":"20","author":"KE Morgenstern","year":"2004","unstructured":"Morgenstern, K. E. et al. Botulinum Toxin Type A for Dysthyroid Upper Eyelid Retraction. Ophthalmic Plast. Reconstr. Surg. 20, 181\u2013185 (2004).","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"89063_CR17","first-page":"1","volume":"2021","author":"D Li","year":"2021","unstructured":"Li, D. & Sun, F. Observations on the efficacy of two methods for the treatment of Upper Eyelid Retraction in thyroid-Associated Ophthalmopathy. Biomed. Res. Int. 2021, 1\u20136 (2021).","journal-title":"Biomed. Res. Int."},{"key":"89063_CR18","first-page":"251584142097911","volume":"12","author":"MH Hussien","year":"2020","unstructured":"Hussien, M. H., Hassan, E. A. E. W. & El-Haddad, N. S. E.-D. M. comparison between hyaluronic acid filler and botulinum toxin type A in the treatment of thyroid upper eyelid retraction. Therapeutic Adv. Ophthalmol. 12, 251584142097911 (2020).","journal-title":"Therapeutic Adv. Ophthalmol."},{"key":"89063_CR19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00417-022-05853-w","volume":"261","author":"M Sales-Sanz","year":"2022","unstructured":"Sales-Sanz, M. et al. M\u00fcllerotomy with anterior graded M\u00fcller muscle disinsertion for Graves upper eyelid retraction: validation of surgical outcomes using B\u00e9zier curves. Graefe\u2019s Archive Clin. Experimental Ophthalmol. 261, 1141\u20131149 (2022).","journal-title":"Graefe\u2019s Archive Clin. Experimental Ophthalmol."},{"key":"89063_CR20","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1080\/01676830.2018.1474237","volume":"38","author":"NG Lee","year":"2018","unstructured":"Lee, N. G., Habib, L., Hall, J. & Freitag, S. K. Simultaneous ipsilateral transconjunctival repair of upper and lower eyelid retraction in thyroid-associated ophthalmopathy. Orbit 38, 124\u2013129 (2018).","journal-title":"Orbit"},{"key":"89063_CR21","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/ceo.12939","volume":"45","author":"ZP Joos","year":"2017","unstructured":"Joos, Z. P. & Sullivan, T. J. Peri-levator palpebrae superioris triamcinolone injection for the treatment of thyroid eye disease-associated upper eyelid retraction. Clin. Exp. Ophthalmol. 45, 651\u2013652 (2017).","journal-title":"Clin. Exp. Ophthalmol."},{"key":"89063_CR22","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/IOP.0000000000002662","volume":"40","author":"RA Awad","year":"2024","unstructured":"Awad, R. A. et al. Peri-levator Betamethasone Versus Triamcinolone Injection in management of thyroid Eye Disease\u2013related Upper Eyelid Retraction without Proptosis. Ophthalmic Plast. Reconstr. Surg. 40, 610\u2013616 (2024).","journal-title":"Ophthalmic Plast. Reconstr. Surg."},{"key":"89063_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/0039-6257(91)90207-V","volume":"36","author":"M Osako","year":"1991","unstructured":"Osako, M. & Keltner, J. L. Botulinum a toxin (Oculinum\u00ae) in ophthalmology. Surv. Ophthalmol.36, 28\u201346 (1991).","journal-title":"Surv. Ophthalmol."},{"key":"89063_CR24","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3109\/01676830903324268","volume":"29","author":"H Salour","year":"2010","unstructured":"Salour, H. et al. Transcutaneous Dysport Injection for Treatment of Upper Eyelid Retraction Associated with thyroid Eye Disease. Orbit 29, 114\u2013118 (2010).","journal-title":"Orbit"},{"key":"89063_CR25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1097\/ICU.0b013e3283499433","volume":"22","author":"M Kazim","year":"2011","unstructured":"Kazim, M. & Gold, K. G. A review of surgical techniques to correct upper eyelid retraction associated with thyroid eye disease. Curr. Opin. Ophthalmol. 22, 391\u2013393 (2011).","journal-title":"Curr. Opin. Ophthalmol."},{"key":"89063_CR26","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.3390\/jcm13103012","volume":"13","author":"Y Kim","year":"2024","unstructured":"Kim, Y. & Lew, H. Synergistic therapy for Graves\u2019 Ophthalmopathy-Associated Eyelid Retraction: Steroid, 5-FU, and Botulinum Neurotoxin a combination. J. Clin. Med. 13, 3012 (2024).","journal-title":"J. Clin. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89063-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89063-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89063-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T13:15:16Z","timestamp":1739279716000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-89063-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["89063"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-89063-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"13 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no financial or proprietary interests in any material discussed in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"5103"}}